Literature DB >> 13201410

Reserpine (serpasil) in the management of the mentally ill and mentally retarded; preliminary report.

R H NOCE, D B WILLIAMS, W RAPAPORT.   

Abstract

Entities:  

Keywords:  MENTAL DEFICIENCY/therapy; MENTAL DISORDERS/therapy; RAUWOLFIA

Mesh：

Substances：

Year:  1954        PMID： 13201410     DOI： 10.1001/jama.1954.02950090017005

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  10 in total

1.  Rauwolfia alkaloids in mental syndromes.

Authors:  H AZIMA; I KENT; R A CLEGHORN
Journal:  Can Med Assoc J       Date:  1955-12-01       Impact factor: 8.262

2.  Rauwolfia serpentina in the control of anxiety.

Authors:  P LOWINGER
Journal:  Psychiatr Q       Date:  1957-07

3.  Use of reserpine and Rauwolfia in psychoneuroses.

Authors:  A FOLKSON; A R MAY
Journal:  Br Med J       Date:  1955-11-05

4.  Hyperchlorhydria induced by intravenous reserpine; response to various therapeutic agents.

Authors:  E M SCHNEIDER; M L CLARK
Journal:  Am J Dig Dis       Date:  1956-01

5.  Rustom Jal Vakil: his contributions to cardiology.

Authors:  Sumit Isharwal; Shubham Gupta
Journal:  Tex Heart Inst J       Date:  2006

6.  [Increase of the glycogen content of the brain and concentration of various enzymes in the brain and intestines of mice after reserpine (serpasil) administration].

Authors:  W ALBRECHT
Journal:  Klin Wochenschr       Date:  1957-06-01

7.  [The Rauwolfia alkaloid, reserpine (serpasil) in psychiatry].

Authors:  F A MIELKE
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1956

8.  Indian Rauwolfia research led to the evolution of neuropsychopharmacology & the 2000 Nobel Prize (Part I).

Authors:  Prakash N Tandon
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375

9.  Indian Rauwolfia research led to the evolution of neuropsychopharmacology & the 2000 Nobel Prize (Part II).

Authors:  Prakash N Tandon
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375

10.  Reserpine methonitrate, a novel quaternary analogue of reserpine augments urinary excretion of VMA and 5-HIAA without affecting HVA in rats.

Authors:  Satyanarayana Sreemantula; Krishna M Boini; Srinivas Nammi
Journal:  BMC Pharmacol       Date:  2004-11-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.